Does an IUD Cause Hormonal Imbalance?

A hormonal IUD does not cause the kind of sweeping hormonal imbalance people often imagine, but it does introduce a synthetic progestin into your body that can shift certain hormonal markers in subtle and sometimes noticeable ways. The distinction that matters is between local and systemic effects: the levonorgestrel released by a hormonal IUD concentrates heavily in the uterus, reaching levels hundreds of times higher than what shows up in your bloodstream. That design limits widespread hormonal disruption, but it doesn’t eliminate it entirely, and the downstream effects on skin, mood, stress hormones, and body composition are real enough to deserve a closer look.

How a Hormonal IUD Actually Delivers Its Hormone

The levonorgestrel-releasing intrauterine system (LNG-IUS) works primarily by flooding the uterine lining with a synthetic progestin called levonorgestrel. The hormone concentrations inside the uterus end up somewhere between 200 and 800 times higher than what you’d get from taking levonorgestrel as a daily pill, while the amount that makes it into your bloodstream stays lower than with other levonorgestrel-containing contraceptives. This is by design. The contraceptive effect comes mainly from thinning the uterine lining and thickening cervical mucus, not from shutting down ovulation the way a combined pill does.

That local-versus-systemic split is why your doctor might tell you the hormonal IUD “doesn’t really affect your hormones.” In a strict pharmacological sense, the systemic exposure is low. But low isn’t zero. Levonorgestrel does reach the bloodstream, and once there, it interacts with androgen receptors and can influence the stress-hormone axis, among other things. How much these trace systemic levels matter varies from person to person, but they’re measurable and, for some women, clinically meaningful.

What Happens to Your Natural Hormone Cycle

One of the most reassuring findings about the hormonal IUD is that it generally leaves your natural menstrual hormone cycle intact. A study following women who had used the LNG-IUS for years found ovulation occurring in the majority of cycles. After six years of use, about 79% of cycles were ovulatory, and complete suppression of ovulation was not observed in any participant. Some cycles showed weaker ovulation or anovulation with ongoing follicular activity, but the overall hormonal rhythm of estrogen and progesterone continued.

This is a major difference from combined oral contraceptives, which suppress ovulation as their main mechanism. With a hormonal IUD, your ovaries keep doing their job. Estradiol rises and falls with follicular development, luteinizing hormone surges at mid-cycle, and progesterone peaks after ovulation. Research on physically active women confirmed that total testosterone concentrations in IUD users fluctuated across the cycle in a normal pattern, peaking at mid-cycle, while women on combined hormonal contraceptives showed flat, suppressed levels of estradiol, progesterone, testosterone, and DHEA throughout.

So when people ask whether a hormonal IUD disrupts their hormonal balance, the answer for the core reproductive hormones is mostly no. Your cycle keeps cycling. The device’s contraceptive power comes from what it does inside the uterus, not from silencing the ovaries.

Testosterone and Androgen Levels

Where the hormonal IUD starts to look different from a copper IUD isn’t in the big reproductive hormones but in the androgens, the group that includes testosterone. A large ancillary study from the ECHO randomized trial compared copper IUD users to women using levonorgestrel implants or injectable progestins. The copper IUD served as the hormone-free baseline. After six months, copper IUD users showed essentially no change in testosterone, sex hormone-binding globulin (SHBG), or free testosterone. Their hormone levels stayed where they started.

The hormonal methods in that study (injectable progestin and implant) did shift androgen markers, but the study’s copper IUD arm is useful context because it tells you what “no hormonal interference” looks like. The hormonal IUD wasn’t tested in that particular trial, but the finding aligns with what other research shows: levonorgestrel-containing methods can interact with androgen pathways, while copper IUDs don’t. Levonorgestrel itself has androgenic properties, meaning it can bind to androgen receptors and mimic some of testosterone’s effects on tissues like skin and hair follicles, even when circulating testosterone levels themselves aren’t dramatically changed.

Why Some Women Break Out After Getting a Hormonal IUD

Acne is probably the most commonly reported hormonal side effect of the LNG-IUS, and it’s one of the clearest signals that the device’s progestin isn’t staying entirely local. The mechanism ties directly to levonorgestrel’s androgenic activity. When levonorgestrel binds to androgen receptors in the skin, it can stimulate oil production and trigger breakouts, even at the relatively low systemic doses the IUD delivers.

A large retrospective study comparing contraceptive classes found that both levonorgestrel IUDs and copper IUDs were associated with a higher risk of acne compared to combined oral contraceptives. The levonorgestrel IUD carried a modestly elevated risk for acne-related clinical visits and was associated with an increased likelihood of needing to escalate acne treatment from topical medications to oral antibiotics.

⁴

For younger women especially, the numbers can be striking. A review focused on adolescents and young women found that the incidence of acne among LNG-IUD users ranged widely depending on the study, but one prospective cohort of women aged 16 to 24 reported acne as a common side effect in 44% of participants during the first year.

⁵

Acne isn’t the only skin-related concern. A broader review of hormonal contraceptives and dermatology noted that progesterone-only methods, including hormonal IUDs, tend to trigger or worsen androgenic skin conditions such as hirsutism (excess hair growth) and alopecia (hair thinning), along with acne.

⁶

This is worth understanding clearly: combined oral contraceptives often improve acne because the estrogen component raises SHBG, which binds up free testosterone and reduces androgenic activity at the skin. The hormonal IUD does the opposite. It delivers a progestin without estrogen, so SHBG doesn’t increase, and levonorgestrel’s own androgenic properties go essentially unopposed. If you switched from a combined pill to a hormonal IUD and your skin got worse, the hormonal explanation is straightforward.

Mood, Depression, and the Psychiatric Question

Whether the hormonal IUD affects mood is one of the most debated questions in contraceptive research, partly because mood is hard to measure objectively and partly because the studies pull in different directions. A systematic review that pooled results from 22 studies found a mixed picture: ten studies reported increased depressive symptoms, two reported reduced symptoms, one showed increased anxiety, one reported elevated suicide risk, four found no association with depression, and four couldn’t reach a firm conclusion but mentioned other psychiatric symptoms.

⁷

That breakdown looks alarming at first, but it also reflects the enormous difficulty of isolating a device’s hormonal effect from everything else going on in someone’s life. Many of these studies lacked control groups, relied on self-report, or couldn’t separate the effect of the IUD from the reason the person chose it (women switching to an IUD after bad experiences on the pill, for example, may already be in a different psychological state). The evidence is strong enough that mood changes shouldn’t be dismissed when a patient reports them, but it’s not strong enough to say the hormonal IUD reliably causes depression.

Sexual Desire and Function

Concerns about lost libido are common with any hormonal contraceptive, and the hormonal IUD gets its share of these worries. The available evidence is largely reassuring. A population-based study found no association between use of the hormonal IUD and lack of interest in sex.

⁸

A study that directly compared women using levonorgestrel IUDs to those using copper IUDs found no meaningful difference in the prevalence of sexual dysfunction between the two groups (about 33% versus 37%, a gap that wasn’t statistically significant). Among the hormonal IUD users who did report changes, the direction wasn’t uniform: some reported increased desire and others decreased desire. Overall, both IUD types had similarly low perceived impact on sexual functioning, and neither group differed in depressive symptoms, general well-being, or relationship quality.

⁹

The likely explanation circles back to ovulation. Because the hormonal IUD doesn’t suppress your natural estrogen and testosterone cycles the way a combined pill does, the hormonal drivers of desire remain mostly intact. Individual experiences still vary widely, but population-level data doesn’t support the idea that the hormonal IUD systematically tanks libido.

Weight and Body Composition

Weight gain is another commonly feared side effect, and the research here tells a more nuanced story than “it makes you gain weight” or “it doesn’t.” A 12-month study found that LNG-IUS users gained an average of about 2.9 kg, compared to 1.4 kg for copper IUD users. However, the difference between the two groups didn’t reach statistical significance. The study did find a significant increase in fat mass among LNG-IUS users (about 2.5%) with a simultaneous decrease in lean mass, while copper IUD users gained more lean mass.

¹⁰

A different 12-month study measuring body composition more broadly found that while lean body mass increased in both LNG-IUS and copper IUD users, changes in overall body weight and composition didn’t differ between the groups.

¹¹

Longer follow-up tells a somewhat different story. A study tracking women for up to ten years found that LNG-IUS users gained an average of about 4 kg over the decade, compared to roughly 5 kg for copper IUD users, a difference that wasn’t statistically significant. Both groups gained considerably less than women on injectable progestins, who averaged about 6.6 kg of gain.

¹²

The practical takeaway is that if the hormonal IUD does affect weight, the effect is small and gets harder to distinguish from normal aging-related weight change the longer you follow people. Some shift in body composition toward more fat and less lean mass is possible in the first year, but it’s not dramatic enough to reliably separate from what happens to women using a hormone-free device.

The Stress Hormone Question

One of the more surprising findings in recent IUD research involves cortisol, the body’s primary stress hormone. A study that subjected women to a standardized laboratory stress test found that hormonal IUD users had a markedly exaggerated cortisol response compared to both naturally cycling women and women on combined oral contraceptives. Hormonal IUD users also had significantly elevated levels of cortisol in their hair, a marker of chronic stress-hormone exposure over months.

¹³

That finding was provocative and got a lot of attention, but it hasn’t been cleanly replicated. A later prospective cohort study that measured hair cortisol in women before and after IUD insertion found no difference in cortisol changes between women who got a levonorgestrel IUD and those who got a copper one. The researchers concluded that hormonal IUDs don’t appear to increase cortisol concentrations or alter stress reactivity based on their data.

¹⁴

The conflicting results are a good reminder that a single study, even a well-designed one, isn’t the last word. The stress-hormone question remains open. If the hormonal IUD does sensitize the stress axis, the effect may depend on individual vulnerability or interact with pre-existing stress levels in ways that are hard to capture in a controlled setting.

What the Hormonal IUD Does Inside the Uterus

Even if the systemic hormonal effects are modest, the local effects inside the uterus are profound and intentional. Research examining the immune environment of the uterus and cervix after LNG-IUS insertion found significant changes: increased concentrations of inflammatory signaling molecules in the cervix, increased density of immune cells including regulatory T cells in the uterine lining, and shifts in the activation state of immune cells throughout the reproductive tract.

¹⁵

A separate study confirmed this local-versus-systemic pattern. After IUD insertion, cytokine levels in the blood didn’t change meaningfully, but cytokine levels in uterine lavage fluid increased, and macrophage activity in the uterine tissue rose in both healthy women and transplant recipients.

¹⁶

These local immune changes are part of how the device works, not an accident. The inflammatory and immune shifts in the uterine lining create an environment hostile to implantation. But they also explain why some women experience cramping, spotting, or changes in discharge, particularly in the first few months. The uterus is genuinely responding to the presence of both the device and the hormone.

The Hormonal IUD and PCOS

Women with polycystic ovary syndrome sometimes worry that a levonorgestrel-releasing device will worsen their already-disrupted androgen levels. The evidence on this is limited but cautiously reassuring. A study that followed women with PCOS using the LNG-IUS for 24 months found that the device did not result in significant changes in clinical or metabolic variables compared to healthy controls.

¹⁷

That said, PCOS is a condition defined by androgen excess, and levonorgestrel is an androgenic progestin. The theoretical concern isn’t unreasonable. In practice, because the systemic dose from the IUD is low, it doesn’t seem to meaningfully worsen the metabolic profile that makes PCOS difficult to manage. But individual responses can differ, and a woman with PCOS who notices worsening acne or hair growth after insertion has a plausible hormonal explanation worth discussing with her provider.

An Unexpected Link to Thyroid Function

One of the more unexpected findings in recent contraceptive research involves the thyroid. A study evaluating the relationship between hormonal contraceptive use and hypothyroidism found that all forms of hormonal contraception, including IUDs, were associated with a lower incidence of hypothyroidism diagnosis. The hormonal IUD showed one of the strongest protective associations, with an odds ratio of about 0.12.

¹⁸

This doesn’t mean the hormonal IUD treats thyroid disease, and the mechanism behind the association isn’t established. It could relate to hormonal contraception’s effects on SHBG, which influences how thyroid hormones are bound and measured in the blood, or it could reflect confounding factors like healthcare access patterns among contraceptive users. But it’s a useful counterpoint to the assumption that any hormonal interference from an IUD must be harmful. Some hormonal shifts may be neutral or even protective, and the full picture of how levonorgestrel interacts with the broader endocrine system is still being mapped.

Copper IUDs as a Hormonal Baseline

Throughout contraceptive research, the copper IUD serves as the de facto control group because it contains no hormones at all. Its contraceptive mechanism relies entirely on the copper ions creating a local inflammatory environment toxic to sperm and eggs. This makes it uniquely useful for isolating the hormonal effects of the LNG-IUS: when you compare copper IUD users to hormonal IUD users and see a difference in androgen levels, body composition, or cortisol, you can be more confident that the difference is driven by levonorgestrel rather than by the experience of having something in the uterus.

The ECHO trial data showed this clearly. Copper IUD users maintained stable testosterone and SHBG levels at six months, serving as the steady reference point against which the hormonal methods’ shifts became visible.

But the copper IUD isn’t without its own effects. The same acne study that found elevated acne risk with levonorgestrel IUDs also found a slightly increased risk with copper IUDs compared to combined pills. This likely reflects the loss of the pill’s estrogen-driven SHBG boost rather than any hormonal action by the copper device itself. In other words, stopping a combined pill and switching to any IUD, hormonal or not, can unmask androgen-driven skin issues that the pill had been suppressing. Separating “the new method caused this” from “the old method was hiding this” is one of the trickiest diagnostic puzzles in contraceptive care.

⁴